Stay updated with breaking news from Tavec Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Global Exosome Market: Size, Forecast, Trials, and Trends, 2023" report has been added to ResearchAndMarkets.com's offering. Exosome...
/PRNewswire/ -- The "Mesenchymal Stem Cells - Advances and Applications, 2022" report has been added to ResearchAndMarkets.com's offering. Today, nearly...
DUBLIN--(BUSINESS WIRE)--The "Mesenchymal Stem Cells - Advances and Applications, 2022" report has been added to ResearchAndMarkets.com's offering.Today, nearly one-hundred different market competitors are developing various types of MSC-related products and services, therapies, and manufacturing technologies. Withi...
ResearchAndMarkets.com’s offering. Exosome-related technologies have been developing rapidly over the past few years and substantial growth is expected for the market as they get integrated into the fields of liquid biopsy, precision medicine and regenerative medicine. In particular, cancer derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely useful source of biomarkers for use in cancer detection, diagnosis, and therapeutic selection. The cargo contained within exosomes can offer prognostic information for...
Share this article Share this article ResearchAndMarkets.com's offering. Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into a variety of cell types, including but not limited to osteoblasts, chondrocytes, myocytes, and adipocytes. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other stem cell types for a variety of reasons, including that they are immuno-privileged, making them an advantageous cel...